Clin2
NCT07226700Possibly a fitRecruiting

Suzetrigine for pain after hip replacement surgery

Total Hip Arthroplasty (THA)Total Hip Arthroplasty \(THA\)Total Hip ReplacementTotal Hip Replacement SurgeryTotal Hip ReplacementsTotal Hip Replacement ArthroplastySuzetriginePain Management

Treatments studied

Part of Brain & nervous system, Pain clinical trials.

This study tests an investigational pain medicine called suzetrigine to see how well it controls pain after total hip replacement surgery. It is for adults 18–80 who are having a first-time hip replacement and can receive spinal anesthesia.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
210 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You are between 18 and 80 years old and scheduled for a first-time total hip replacement using a posterior approach.
  • You plan to be discharged home (not to a rehab facility) and will receive neuraxial anesthesia (like a spinal block).
  • You have not taken strong pain medicines (opioids) daily for the past 3 months or more.
  • You do not have long-term pain conditions like fibromyalgia, complex regional pain syndrome, or a spinal cord stimulator.
  • You do not have a pacemaker, defibrillator, or a history of QT prolongation (a heart rhythm issue), and no moderate to severe liver disease.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07672015Recruiting· Phase 4
Testing a new pain drug in surgery patients at risk for opioid dependence

This trial tests a new painkiller called suzetrigine for post-surgery pain. It's designed for people whose medical records suggest they may have a higher chance of needing strong painkillers (opioids) long after surgery. We want to see if suzetrigine works better at preventing that.

La Jolla, California
NCT07538570Recruiting· Phase 4
Pain Management After Knee Replacement Surgery

This study tests different pain treatments for patients undergoing total knee replacement surgery. The goal is to find the most effective way to manage pain after this common procedure.

Bellaire, Texas
NCT07534709Not yet recruiting· Phase 4
Suzetrigine for Pain Relief After Cesarean Delivery Without Opioids

This study tests whether a new pain medication called suzetrigine can help you recover comfortably after a cesarean delivery without needing strong opioid painkillers. You'll receive the study drug and complete follow-up check-ins for two weeks after surgery.

Austin, Texas
NCT07654296Not yet recruiting· Phase 3
Testing a new pain medicine after ureteroscopy

This trial tests a new pain medication called suzetrigine to see how well it reduces pain after ureteroscopy, a common procedure for kidney stones. If you are having this surgery, you may be able to join and get a treatment that could help you manage pain with fewer side effects.

Boston, Massachusetts
NCT07348627Recruiting· Phase 3
Opioid-free hip replacement study

This trial tests if using fewer opioids after hip replacement surgery can still control pain well. It uses a specific type of hip replacement called anterior total hip arthroplasty and aims to help patients recover with less reliance on strong pain medicines.

Atlanta, Georgia
NCT07548385Recruiting· Phase 3
New pain medicine for after knee replacement surgery

This study tests a new medication called suzetrigine to help manage pain after knee replacement surgery. The goal is to see if it reduces pain and discomfort better than current treatments.

New York, New York

Hear when a new Total Hip Arthroplasty (THA) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.